Е А Катунина

524 total citations
49 papers, 322 citations indexed

About

Е А Катунина is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Е А Катунина has authored 49 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 10 papers in Neurology. Recurrent topics in Е А Катунина's work include Parkinson's Disease Mechanisms and Treatments (28 papers), Neurological disorders and treatments (18 papers) and Genetic Neurodegenerative Diseases (8 papers). Е А Катунина is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (28 papers), Neurological disorders and treatments (18 papers) and Genetic Neurodegenerative Diseases (8 papers). Е А Катунина collaborates with scholars based in Russia, United Kingdom and United States. Е А Катунина's co-authors include Nataliya Titova, К. Ray Chaudhuri, Pablo Martínez‐Martín, О С Левин, Peter Jenner, Wolfgang H. Oertel, Richard Dodel, Jens Peter Reese, Yaroslav Winter and Jens Klotsche and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Movement Disorders.

In The Last Decade

Е А Катунина

41 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Е А Катунина Russia 9 239 90 42 40 37 49 322
Reinhard Ehret Germany 10 366 1.5× 108 1.2× 33 0.8× 53 1.3× 25 0.7× 18 443
Sang‐Won Yoo South Korea 11 268 1.1× 65 0.7× 31 0.7× 44 1.1× 37 1.0× 40 361
Albert Stezin India 11 233 1.0× 109 1.2× 42 1.0× 28 0.7× 46 1.2× 49 364
Guanglu Li China 9 226 0.9× 73 0.8× 29 0.7× 43 1.1× 30 0.8× 16 368
Chizoba C. Umeh United States 10 215 0.9× 76 0.8× 41 1.0× 33 0.8× 64 1.7× 18 329
Kelly Bertram Australia 11 292 1.2× 112 1.2× 48 1.1× 21 0.5× 34 0.9× 22 367
Prasad Korlipara United Kingdom 7 137 0.6× 52 0.6× 29 0.7× 28 0.7× 40 1.1× 12 258
Paola Stirpe Italy 10 338 1.4× 120 1.3× 46 1.1× 44 1.1× 36 1.0× 12 403
Philip W. Tipton United States 11 142 0.6× 69 0.8× 72 1.7× 19 0.5× 50 1.4× 44 292
Joel Gutiérrez Cuba 7 159 0.7× 76 0.8× 44 1.0× 21 0.5× 34 0.9× 18 305

Countries citing papers authored by Е А Катунина

Since Specialization
Citations

This map shows the geographic impact of Е А Катунина's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Е А Катунина with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Е А Катунина more than expected).

Fields of papers citing papers by Е А Катунина

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Е А Катунина. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Е А Катунина. The network helps show where Е А Катунина may publish in the future.

Co-authorship network of co-authors of Е А Катунина

This figure shows the co-authorship network connecting the top 25 collaborators of Е А Катунина. A scholar is included among the top collaborators of Е А Катунина based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Е А Катунина. Е А Катунина is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martynov, M. Yu., et al.. (2025). Dynamics of permeability of the blood-brain barrier after FUS thalamotomy according to contrast-enhanced MRI. Burdenko s Journal of Neurosurgery. 89(4). 51–51. 1 indexed citations
2.
Катунина, Е А, et al.. (2025). The Results of a 12-Month Open-Label Follow-Up Study with MRI Monitoring of Patients with Parkinson’s Disease After MRI-Guided FUS. Journal of Clinical Medicine. 14(23). 8329–8329.
3.
Катунина, Е А, et al.. (2025). Art and creativity in Parkinson’s disease: the mysterious effects of dopamine. S S Korsakov Journal of Neurology and Psychiatry. 125(4). 13–13.
4.
Катунина, Е А, et al.. (2025). Parkinson's disease and migraine. Neurology neuropsychiatry Psychosomatics. 17(3). 98–103.
5.
Катунина, Е А, et al.. (2025). Epidemiology of Parkinson’s disease. S S Korsakov Journal of Neurology and Psychiatry. 125(11). 39–39.
6.
Катунина, Е А, et al.. (2025). A prospective study of MRI-guided focused ultrasound thalamotomy in essential tremor. S S Korsakov Journal of Neurology and Psychiatry. 125(9). 79–79.
7.
Катунина, Е А, et al.. (2024). The complex effect of polyphenols on the gut microbiota and triggers of neurodegeneration in Parkinson’s disease. S S Korsakov Journal of Neurology and Psychiatry. 124(1). 38–38. 1 indexed citations
8.
Катунина, Е А, et al.. (2024). Tremor-dominant form of Parkinson’s disease. S S Korsakov Journal of Neurology and Psychiatry. 124(4). 28–28. 1 indexed citations
9.
Катунина, Е А, et al.. (2023). Parkinson’s disease. Focus on early stages. SHILAP Revista de lepidopterología. 15(3). 95–103. 4 indexed citations
10.
Titova, Nataliya, et al.. (2023). Asthenia, mental fatigue and cognitive dysfunction. S S Korsakov Journal of Neurology and Psychiatry. 123(5). 38–38. 4 indexed citations
11.
Боголепова, А Н, Gavrilova Si, С. Н. Иллариошкин, et al.. (2022). Roadmap for ecosystem-based approach for patients with Alzheimer disease in Russia: current needs, barriers, and possible solutions (resolution of the scientific and practical experts meeting). S S Korsakov Journal of Neurology and Psychiatry. 122(7). 121–121. 3 indexed citations
12.
Катунина, Е А, et al.. (2022). First experience of thalamotomy by focused ultrasound under MR-guided navigation in the treatment of tremor. Neuroimaging follow-up. Case report and literature review. Burdenko s Journal of Neurosurgery. 86(5). 81–81. 2 indexed citations
13.
Titova, Nataliya, et al.. (2022). The problem of pharmacoresistant tremor in Parkinson’s disease and essential tremor. S S Korsakov Journal of Neurology and Psychiatry. 122(10). 24–24. 2 indexed citations
14.
Titova, Nataliya, et al.. (2021). Genetic Markers as Risk Factors for the Development of Impulsive-Compulsive Behaviors in Patients with Parkinson’s Disease Receiving Dopaminergic Therapy. Journal of Personalized Medicine. 11(12). 1321–1321. 7 indexed citations
15.
Гусев, Е. И., M. Yu. Martynov, Е А Катунина, et al.. (2021). Development of early diagnosis of Parkinson’s disease and comprehensive economic analysis of the effect of its implementation. S S Korsakov Journal of Neurology and Psychiatry. 121(1). 9–9. 2 indexed citations
16.
Гусев, Е. И., Е А Катунина, А. Л. Калинкин, et al.. (2020). Development of early diagnosis of Parkinson’s disease based on the search for biomarkers such as premotor symptoms and changes in blood. S S Korsakov Journal of Neurology and Psychiatry. 120(12). 7–7. 3 indexed citations
17.
Блинов, Д. В., et al.. (2019). Restrictions on the use of valproate in female patients of reproductive age: the updated recommendations based on recent clinical data. SHILAP Revista de lepidopterología. 11(2). 110–123. 10 indexed citations
18.
Selikhova, Marianna, Е А Катунина, & Alan Whone. (2019). PET and SPECT in the assessment of monoaminergic brain systems in extrapyramidal disorders. SHILAP Revista de lepidopterología. 13(2). 69–78. 2 indexed citations
19.
Titova, Nataliya, О С Левин, Е А Катунина, & К. Ray Chaudhuri. (2018). ‘Levodopa Phobia’: a review of a not uncommon and consequential phenomenon. npj Parkinson s Disease. 4(1). 31–31. 33 indexed citations
20.
Winter, Yaroslav, Е А Катунина, Jens Peter Reese, et al.. (2010). Incidence of Parkinson's disease and atypical parkinsonism: Russian population‐based study. Movement Disorders. 25(3). 349–356. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reinhard Ehret Breakdown of academic impact, for papers by Sang‐Won Yoo Breakdown of academic impact, for papers by Albert Stezin Breakdown of academic impact, for papers by Guanglu Li Breakdown of academic impact, for papers by Chizoba C. Umeh Breakdown of academic impact, for papers by Kelly Bertram Breakdown of academic impact, for papers by Prasad Korlipara Breakdown of academic impact, for papers by Paola Stirpe Breakdown of academic impact, for papers by Philip W. Tipton Breakdown of academic impact, for papers by Joel Gutiérrez
Rankless by CCL
2026